Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunao Tanaka

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
The Journal of Urology|October 3, 2025
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial CarcinomaKazutoshi Fujita, Makito Miyake, Mamoru Hashimoto, et al.
Journal of Translational Medicine|May 9, 2026
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international studyYair Lotan, Satoshi Anai, Howard Kim, et al.
Cancer Science|October 8, 2024
Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumorsTomomi Nishimura, Ravi Velaga, Norikazu Masuda, et al.
British Journal of Cancer|January 18, 2024
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patientsDon Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda, et al.
Molecules and Cells|December 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid TumorsMasamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, et al.
The Journal of Clinical Investigation|May 23, 2017
Genetic regulation of the RUNX transcription factor family has antitumor effectsKen Morita, Kensho Suzuki, Shintaro Maeda, et al.
The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.
The Journal of Pathology|August 23, 2023
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJeppe Thagaard, Glenn Broeckx, David B Page, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Experimental and Molecular Pathology|March 17, 2026
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerToru Sakatani, Sunao Tanaka, Kaoru Murakami, et al.
The Journal of Urology|October 3, 2025
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial CarcinomaKazutoshi Fujita, Makito Miyake, Mamoru Hashimoto, et al.
Journal of Translational Medicine|May 9, 2026
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international studyYair Lotan, Satoshi Anai, Howard Kim, et al.
Cancer Science|October 8, 2024
Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumorsTomomi Nishimura, Ravi Velaga, Norikazu Masuda, et al.
British Journal of Cancer|January 18, 2024
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patientsDon Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda, et al.
Molecules and Cells|December 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid TumorsMasamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, et al.
The Journal of Clinical Investigation|May 23, 2017
Genetic regulation of the RUNX transcription factor family has antitumor effectsKen Morita, Kensho Suzuki, Shintaro Maeda, et al.
The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.
The Journal of Pathology|August 23, 2023
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJeppe Thagaard, Glenn Broeckx, David B Page, et al.
Pageof 7